Stephanie Campbell

Stephanie Campbell is a Senior Regional Medical Director at Dynavax Technologies since September 2021, bringing extensive experience in medical science and liaison roles from notable companies. Previously, Stephanie served as Interim Medical Director and Director of Medical Science Liaisons at Emergent BioSolutions from May 2019 to September 2021, and held a Medical Science Liaison position at GSK from March 2015 to May 2019, focusing on vaccine education and collaboration with infectious disease experts. Stephanie's career also includes significant roles at Novartis Vaccines, where responsibilities encompassed team mentorship, educational material development, and grant program coordination, along with earlier laboratory experience as a Postdoctoral Fellow at Lovelace Respiratory Research Institute and as a Graduate Student at Duke University, where research focused on molecular virology and cancer therapeutics. Stephanie holds a PhD in Molecular Genetics & Microbiology from Duke University and a BA in Biology and Mathematics from Albion College.